Metabolic activation of trichloroethylene into a chemically reactive metabolite toxic to the liver. 1978

H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou

The mechanism for trichloroethylene hepatotoxicity was investigated in male Sprague-Dawley rats. Phenobarbital pretreatment increased and CoCl2 pretreatment decreased trichloroethylene hepatotoxicity. After administration of 1(14)C]trichloroethylene, a radioactive material became irreversibly bound to hepatic proteins, while negligible amounts were bound to muscle proteins. When 1(14)C]trichloroethylene was incubated under air with hepatic microsomes and a NADPH-generating system, a radioactive material became irreversibly bound to microsomal proteins; binding was negligible when the NADPH-generating system was omitted; binding was inhibited by carbon monoxide and by piperonyl butoxide; the amount of bound material was greater with microsomes from phenobarbital-pretreated rats and lower with microsomes from CoCl2-pretreated rats than with microsomes from nonpretreated rats. Trichloroethylene administration decreased hepatic glutathione in normal rats but not in piperonyl butoxide-pretreated rats; in vitro, glutathione decreased the amount of trichloroethylene material that bound to microsomal proteins. The reported results are consistent with the view that 1) trichloroethylene is metabolized by cytochrome P-450 into a chemically reactive metabolite which reacts with, and binds to, either proteins or glutathione, 2) binding to proteins produces liver lesions and 3) binding to glutathione decreases the amount of reactive metabolite available for binding to proteins.

UI MeSH Term Description Entries
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003035 Cobalt A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis. Cobalt-59,Cobalt 59
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D014241 Trichloroethylene A highly volatile inhalation anesthetic used mainly in short surgical procedures where light anesthesia with good analgesia is required. It is also used as an industrial solvent. Prolonged exposure to high concentrations of the vapor can lead to cardiotoxicity and neurological impairment. Ethinyl Trichloride,Trichloroethene,Trielina,Trilene,Trichloride, Ethinyl

Related Publications

H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
January 1977, Communications in psychopharmacology,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
October 1976, The Journal of pharmacology and experimental therapeutics,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
January 1995, Chemical research in toxicology,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
January 1982, Drug metabolism and disposition: the biological fate of chemicals,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
October 1951, Medizinische Klinik,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
June 2004, Drug metabolism and disposition: the biological fate of chemicals,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
November 2014, Xenobiotica; the fate of foreign compounds in biological systems,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
March 1979, Journal of medicinal chemistry,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
January 1981, Advances in experimental medicine and biology,
H Allemand, and D Pessayre, and V Descatoire, and C DeGott, and G Feldmann, and J P Benhamou
July 1979, Toxicology and applied pharmacology,
Copied contents to your clipboard!